[{"address1": "19 Vestry Street", "city": "New York", "state": "NY", "zip": "10013", "country": "United States", "phone": "647 865 8622", "website": "https://brightmindsbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indications. Bright Minds Biosciences Inc. has collaboration with National Institutes of Health for the treatment of epilepsy; University of Texas Medical Branch to treat impulse control disorders, such as binge eating; and Medical College of Wisconsin. The company was founded in 2017 and is headquartered in New York, New York.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Ian  McDonald", "age": 62, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1962, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan E. S. K. Cheung B.Com., CA, CPA", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 84559, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jan Torleif Pedersen M.Sc., Ph.D.", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 171444, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Alex  Vasilkevich", "title": "COO & VP of Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Emer  Leahy M.B.A., Ph.D.", "age": 58, "title": "Consultant", "yearBorn": 1966, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen D. Collins M.D., Ph.D.", "age": 71, "title": "Chief Medical Officer", "yearBorn": 1953, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 36.15, "open": 36.27, "dayLow": 36.0, "dayHigh": 37.055, "regularMarketPreviousClose": 36.15, "regularMarketOpen": 36.27, "regularMarketDayLow": 36.0, "regularMarketDayHigh": 37.055, "payoutRatio": 0.0, "beta": 0.494, "volume": 54899, "regularMarketVolume": 54899, "averageVolume": 106654, "averageVolume10days": 66770, "averageDailyVolume10Day": 66770, "bid": 35.59, "ask": 36.93, "bidSize": 1, "askSize": 1, "marketCap": 255787008, "fiftyTwoWeekLow": 0.93, "fiftyTwoWeekHigh": 79.02, "fiftyDayAverage": 38.0458, "twoHundredDayAverage": 18.066965, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 196926272, "forwardPE": -8.267001, "profitMargins": 0.0, "floatShares": 2593597, "sharesOutstanding": 7043990, "sharesShort": 137699, "sharesShortPriorMonth": 176685, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0195, "heldPercentInsiders": 0.24258, "heldPercentInstitutions": 0.72511, "shortRatio": 1.49, "shortPercentOfFloat": 0.0287, "impliedSharesOutstanding": 7092420, "bookValue": 8.274, "priceToBook": 4.3887844, "lastFiscalYearEnd": 1727654400, "nextFiscalYearEnd": 1759190400, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -1068069, "trailingEps": -0.14, "lastSplitFactor": "1:5", "lastSplitDate": 1689292800, "52WeekChange": 18.228724, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 36.3128, "targetHighPrice": 92.60238, "targetLowPrice": 92.60238, "targetMeanPrice": 92.60238, "targetMedianPrice": 92.60238, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 57896664, "totalCashPerShare": 8.219, "totalDebt": 182733, "quickRatio": 125.592, "currentRatio": 126.151, "debtToEquity": 0.316, "returnOnAssets": -0.04926, "returnOnEquity": -0.03345, "freeCashflow": -1400343, "operatingCashflow": -2522493, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "CAD", "symbol": "DRUG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "regularMarketTime": 1740169304, "regularMarketChangePercent": 0.4503453, "regularMarketPrice": 36.3128, "exchange": "NCM", "messageBoardId": "finmb_691048918", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "marketState": "REGULAR", "longName": "Bright Minds Biosciences Inc.", "shortName": "Bright Minds Biosciences Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616419800000, "regularMarketChange": 0.16279984, "regularMarketDayRange": "36.0 - 37.055", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 106654, "fiftyTwoWeekLowChange": 35.3828, "fiftyTwoWeekLowChangePercent": 38.04602, "fiftyTwoWeekRange": "0.93 - 79.02", "fiftyTwoWeekHighChange": -42.707195, "fiftyTwoWeekHighChangePercent": -0.5404606, "fiftyTwoWeekChangePercent": 1822.8723, "epsTrailingTwelveMonths": -0.14, "epsCurrentYear": -2.2, "priceEpsCurrentYear": -16.50582, "fiftyDayAverageChange": -1.7329979, "fiftyDayAverageChangePercent": -0.04555031, "twoHundredDayAverageChange": 18.245836, "twoHundredDayAverageChangePercent": 1.0099005, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-08", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "displayName": "Bright Minds Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]